Rectal NETs and Rectosigmoid Junction NETs May Need to Be Treated Differently
#2767
Introduction: Neuroendocrine tumours (NETs) are heterogeneous, and the incidence of colorectal NETs is rapidly increasing.
Aim(s): We observed different survival in patients with rectal NETs and rectosigmoid junction NETs, which are unreasonable to be treated similarly.
Materials and methods: We included patients from SEER database. Patients with a rectal NET diagnosis between 2000 and 2016 who met our criteria were included. The 5-year survival was set as the end-point.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Cai W
Authors: Cai W, Ge W, Mao J, Hu h,
Keywords: Rectal neuroendocrine tumor, rectosigmoid junction, SEER database, Survival,
To read the full abstract, please log into your ENETS Member account.